KM

Kapil Madan

Director Director DIN 09640517
DIN 09640517 First appointment Jun 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2022
Shareholding value Locked Premium profile

About Kapil Madan

Data last updated:

Kapil Madan has 4 years in corporate governance. Formerly with 1 company, such as Docxis Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09640517
Primary Designation Director
First Appointment 16 Jun 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Docxis Life Sciences Private Limited U24299DL2022PTC400118
Director16 Jun 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Docxis Life Sciences Private Limited
Premium access

Shareholding and investment profile for Kapil Madan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kapil Madan

Kapil Madan has 4 years in corporate governance. Formerly with 1 company, such as Docxis Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.

Kapil Madan is associated with 0 companies as a director.

Kapil Madan has expertise in General Business.

Kapil Madan has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available